Source: pixabay

The A-share listed companies actually controlled by Haier Group will be added by one more.

On February 16, Xinshida (002527. SZ) announced that Haier Kaos Industrial Intelligence signed the "Share Transfer Agreement" and the "Voting Rights Entrustment Agreement" with Ji Defa, Liu Liping and Ji Yi, which stipulated that Ji Defa, Liu Liping and Ji Yi would transfer a total of 10% of the company's shares to Haier Kaos Industrial Intelligence, and irrevocably entrust the voting rights of the listed company (accounting for 19.24% of the total number of shares of the listed company) held by the remaining shares of the listed company after the completion of the share transfer to Haier Kaos Industrial Intelligence.

After the completion of the transfer of the agreement, the entrustment of voting rights and the concerted action arrangement, Haier Kaos Industrial Intelligence will become the controlling shareholder of the listed company, and Haier Group will become the actual controller of the listed company. Trading in the Company's shares will resume from the market open on Monday, February 17, 2025.

In response to the follow-up business of Haier Group's acquisition of Xinshida, Times Weekly contacted the relevant person in charge of Haier Group, but as of press time, no reply has been received.

The buyer has settled, and Haier has gone deep into the industrial robot track

On February 9, Xinshida announced that the company's controlling shareholder and actual controller are planning the transfer of control of the company. If the above matters are achieved, it will lead to a change of control of the company.

After a few days of suspension of trading in the planned change of control, the final buyer was settled. In the eyes of industry insiders, Haier Group's takeover is not unexpected.

"Haier Group often enters a new field and new market through acquisitions, and the acquisition of Xinshida is also in line with the diversified development strategy, expanding from the original B2C to the B2B field. In addition, the future growth prospects of industrial robots are clear, and their internal core technologies can be used for Haier's future humanoid robots and automation development. Liang Zhenpeng, a senior observer of industrial economics, told a reporter from Times Weekly.

Founded in 1995, Xinshida was originally the leading elevator company in China, and the main business of elevator manufacturers, including Xinshida, gradually shrank due to the impact of real estate market fluctuations. As of February 16, the market value of Xinshida was 6.7 billion yuan, which has shrunk by nearly two-thirds in 10 years.

However, Xinshida seized the key node of transformation earlier. In 2013, Xinshida entered the industrial robot track, supporting the second curve of the company's growth.

From 2014 to 2015, Xinshida successively won 100% of the shares of Zhongweixing and Huitong Technology through acquisitions, as well as part of the shares of Xiaoao Xiangrong, to achieve a rapid layout in the field of motion control and robotics. At the end of 2015, the company's share price reached a peak of 31.89 yuan per share, with a market value of more than 20 billion yuan.

In 2016, the founder Ji Defa officially resigned and handed over the company to his daughter Ji Yi. After the company completed the replacement of new and old powers, the new Shida ushered in an inflection point in its development. During this period, the company's management changed frequently, and its performance fell into fluctuations.

In 2018, Xinshida lost 261 million yuan, and from 2019 to 2021, it achieved continuous profits, and since then, Xinshida has fallen into losses again. From 2021 to 2022, Xinshida's losses will be 1.057 billion yuan and 379 million yuan respectively, with a total loss of 1.436 billion yuan in two years.

According to the latest performance forecast, Xinshida expects a net profit loss attributable to the parent company of 185 million yuan to 367 million yuan in 2024, and a non-net profit loss of 232 million yuan to 414 million yuan.

Xinshida previously said in the reception of institutional investors that the company's robot ontology has been continuously expanding relying on more than ten years of control technology, and currently mainly includes multi-joint robots, Zhongweixing SCARA robots, semiconductor robots and other categories. Products are widely used in 3C, semiconductor, auto parts and other industries.

According to data from MIR Rui Industry, an industry consulting agency, in the first half of 2024, the sales volume of Xinshida industrial robot products will rank fourth in China and tenth in the world.

With actual control of 6 A-share listed companies, Haier broadens its diversified territory

In less than a year, this is the second time that Haier Group has made a move to win an A-share listed company.

After ending the 20-year golden period of growth, the three giants of domestic home appliances have started the road of transformation. Among them, Haier Group mainly lays out three major tracks: smart residential ecology, big health industry ecology and digital economy industry ecology.

On June 18, 2024, Shanghai RAAS (002252. SZ) announced that Haier Group acquired 20% of the shares of Shanghai RAAS held by Grifols, a shareholder of Shanghai RAAS, at a total price of 12.5 billion yuan through Haiyingkang (Qingdao) Medical Technology Co., Ltd., and obtained a total of 26.58% of the voting rights, completed the delivery, and became the new actual controller.

In December of the same year, Haier Biotech announced that it planned to absorb and merge Shanghai RAAS. Before the news was released, the market value of Haier Biotechnology was about 11.2 billion yuan, and the market value of Shanghai RAAS was about 47.9 billion yuan. This transaction is also seen by the market as a "snake swallowing an elephant" merger.

On January 6, 2025, Haier Biotech announced that it would terminate the major asset restructuring of the planned absorption and merger of Shanghai RAAS, because "the transaction structure is relatively complex and a specific plan approved by relevant parties has not yet been formed".

From medical platforms to blood products, smart management and other subdivisions, Haier Group is trying to realize the ecological closed loop in the field of big health, and its medical empire is gradually emerging.

To a certain extent, Xinshida's precipitation in the field of control systems and Haier Group's long-term deep cultivation of smart home and big health industries can be combined, such as the development of humanoid robots for home and medical scenarios to expand new growth points.

"The control system is an important component of humanoid robots, and Xinshida Electric Co., Ltd. is an important supplier in the market, and its factory production line can help Haier Group accelerate the pace of production and research and development." Liang Zhenpeng said.

At present, Haier Group continues to expand its A-share territory, and its subsidiaries include Shanghai RAAS, Yingkang Life (300143.SZ), Haier Smart Home (600690.HK). SZ), Haier Biotech (688139. SH), Leishen Technology (872190. BJ) and other A-share listed companies.